PubMed · 2026

Safety, Pharmacokinetics and Pharmacodynamics of the GLP-1/GIP/GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study

Yang GP, Liu YX, Xie JL, et al. (2026). Safety, Pharmacokinetics and Pharmacodynamics of the GLP-1/GIP/GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo-Controlled Phase 1a/1b Study. Diabetes Obes Metab.

Diabetes Obes Metab

Source: https://pubmed.ncbi.nlm.nih.gov/42712041/

Last reviewed September 19, 2026. By the PeptIQ team.

View original source

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.